Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;41(3):206-14.
doi: 10.1080/00365540902721376.

HIV and HCV discordant injecting partners and their association to drug equipment sharing

Prithwish De  1 , Joseph Cox, Jean-Francois Boivin, Robert W Platt, Ann M Jolly, Paul E Alexander
Affiliations

HIV and HCV discordant injecting partners and their association to drug equipment sharing

Prithwish De et al. Scand J Infect Dis. 2009.

Abstract

Our objective was to examine the association between HIV and HCV discordant infection status and the sharing of drug equipment by injection drug users (IDUs). IDUs were recruited from syringe exchange and methadone treatment programmes in Montreal, Canada. Characteristics of participants and their injecting partners were elicited using a structured questionnaire. Among 159 participants and 245 injecting partners, sharing of syringes and drug preparation equipment did not differ between concordant or discordant partners, although HIV-positive subjects did not share with HIV-negative injectors. Sharing of syringes was positively associated with discordant HIV status (OR=1.85) and negatively with discordant HCV status (OR=0.65), but both results were not statistically significant. Sharing of drug preparation equipment was positively associated with both discordant HIV (OR=1.61) and HCV (OR=1.18) status, but both results were non-significant. Factors such as large injecting networks, frequent mutual injections, younger age, and male gender were stronger predictors of equipment sharing. In conclusion, IDUs do not appear to discriminate drug equipment sharing partners based at least on their HCV infection status. The results warrant greater screening to raise awareness of infection status, post-test counselling to promote status disclosure among partners, and skill-building to avoid equipment sharing between discordant partners.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

    1. Roy E, Alary M, Morissette C, Leclerc P, Boudreau J, Parent R, et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS. 2007;18:23–7. - PubMed
    1. Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev. 2005;17:170–84. - PubMed
    1. Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Beatrice S, Milliken J, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19(Suppl 3):S20–5. - PubMed
    1. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviours among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:202–7. - PubMed
    1. Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, Koester S, et al. HIV risk behaviours associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse. 1998;33:2403–23. - PubMed

Publication types

Grants and funding